VC firm

Windham Venture Partners

Kingmaker Tier

Kingmaker Tier: 91 out of 100

Also known as Windham Life Sciences, Windham Life Sciences Partners IV, L.P.

Investor type: VC
Investing status: Activeas of 2026-09-19Source (opens in a new tab)
Headquarters: New York, NY, United States
Assets under management: $94.1MForm ADV private fund GAV, as of 2025-07-17Source (opens in a new tab)
Latest fund size: $30.8MSEC amount sold, as of 2024-11-15Source (opens in a new tab)
Funds: 7
Legal name: WINDHAM CAPITAL PARTNERS LLC

Record updated 30 September 2026

About

Investing in life-saving, game-changing HealthTech

Thesis: We use our special relationships to access and build disruptive healthcare technology companies that survive our intensive due diligence, hold the promise to change the face of healthcare by satisfying unmet medical needs in large markets, and result in better care and longer life. By doing so, we will fulfill our responsibility to provide our investors with significant returns.Source (opens in a new tab)
Takes board seats: Yes
Eligibility: We assess a company's likelihood of success based on the following standards:
Traction requirement: has generated impressive data demonstrating its technology or product works
Investing status notes: Windham Capital Partners is interested in hearing from prospective investors, entrepreneurs, and senior executives at start-up companies seeking capital and partnership.

Windham Life Sciences Partners IV, L.P.: $30.8MVintage 2023, Main fund, SEC amount sold
WINDHAM LIFE SCIENCES PARTNERS III, L.P.: Main fund
WINDHAM LIFE SCIENCES PARTNERS II ANNEX FUND, L.P.: Annex
WLSP COINVESTMENT, LLC: SPV
WINDHAM-CRV INVESTMENT I, LLC: Main fund
WINDHAM LIFE SCIENCES PARTNERS, L.P.: Main fund
WINDHAM LIFE SCIENCES PARTNERS II, L.P.: Main fund

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.